Jointly provided by
|
This activity is supported by an independent educational grant from Dexcom, Inc.
|
Thursday, April 23, 2020
6:00 PM - 8:00 PM
George R. Brown Convention Center
Room: 381
Houston, TX
Please note: Registration for AMCP 2020 is not required to attend this symposium.
|
|
Due to the recent outbreak of COVID-19, AMCP has made the decision to cancel their annual meeting in Houston. For more information about this cancellation, please visit AMCP's website: www.amcpmeetings.org. In the meantime, please visit the Impact Education, LLC ® website for more free CE opportunities on current managed care topics.
www.impactedu.net
|
|
Learn About
|
- How CGM can help reduce the clinical and economic burden of hypoglycemic events
- Latest consensus guidelines and evidence-based care in diabetes
- The value of CGM as part of a comprehensive diabetes management strategy
- Best practices in pharmacy and benefit design strategies for precision diabetes management
|
Expert Faculty Presenters
|
|
|
|
|
Daniel DeSalvo, MD
Assistant Professor
Pediatric Endocrinologist
Baylor College of Medicine
Texas Children's Hospital
|
|
Jeffrey Dunn, PharmD, MBA
(Formerly) Vice President, Clinical Strategy and Programs and Industry Relations
Magellan Rx Management
|
|
Troy Ross
President & CEO
Mid-America Coalition on Health Care
|
|
|
|
Who Should Attend?
|
This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP 2020 Meeting.
|
|
Statement of Need/Program Overview
|
The vast majority of plan members with diabetes have an A1C above ADA targets, putting them at risk for other costly comorbidities. To effectively address these clinical challenges and elicit improvements across 29 indices of glycemic control and glycemic variability, continuous glucose monitoring (CGM) has been endorsed by various professional endocrinology-centered organizations. In 2017, the Centers for Medicare and Medicaid Services (CMS) Medicare made a milestone ruling, establishing benefit coverage for "therapeutic" CGM — a designation applying to those CGM systems approved for use in making treatment decisions without a fingerstick (non-adjunctive use ). This program will elucidate the burden of diabetes and describe multifaceted clinical and administrative strategies across the medical and pharmacy benefits to promote quality care and manage costs while improving outcomes for affected plan members.
|
|
Educational Objectives
|
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Characterize the clinical and economic burden of hypoglycemic events in terms of health care resource utilization, indirect costs, and member quality of life
- Review the most recent consensus guidelines and evidence-based care in the management of diabetes
- Characterize the role and value of CGM as part of a comprehensive diabetes management strategy
- Employ pharmacy and benefit design strategies that include precision diabetes management paramount to quality care and optimal outcomes via CGM
|
|
Agenda
|
Date and Time
Thursday, April 23, 2020
6:00 PM - 8:00 PM
George R. Brown Convention Center
Room: 381
Houston, TX
|
|
6:00 PM
|
Pre-Activity Learning Assessment and Opening Comments/Overview
Jeffrey Dunn, PharmD, MBA
|
|
6:05 PM
|
Clinical and Economic Consequences of Imprecise Glycemic Management
Daniel DeSalvo, MD
|
|
6:45 PM
|
Implementing CGM: Real World Insights
Jeffrey Dunn, PharmD, MBA
|
|
7:15 PM
|
Optimal Clinical and Economic Outcomes in Diabetes: The Employer Perspective
Troy Ross
|
|
7:45 PM
|
Audience Q&A Session
|
|
7:55 PM
|
Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
|
|
8:00 PM
|
Adjournment
|
|
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER) and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources, Inc. designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Credit
 |
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 08169-9999-20-121-L01-P
This activity is certified as Knowledge-based CPE.
|
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CME/CPE activity.
Registration for AMCP 2020 is not required to attend this symposium.
Pre-registration will close at 12:00 pm on April 22, 2020.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
|
|
